Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All Insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Secondary marketplace / Trade private companies / Buy and sell Zenas BioPharma stock
Zenas BioPharma

Zenas BioPharma stock

$--
Register to buy and sell private company shares
For more details on financing and valuation of private companies similar to Zenas BioPharma before its IPO, register or login today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

Zenas BioPharma stock price

Price history chart

7D
1M
3M
1Y
All
Forge Price
$--
Not yet available
Forge Price valuation
$--

Most active Healthcare companies

Zenas BioPharma stock FAQs

To buy and sell Zenas BioPharma stock

Can you buy Zenas BioPharma stock?

You can no longer buy Zenas BioPharma stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Zenas BioPharma stock?

You can no longer buy Zenas BioPharma stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

Can you sell Zenas BioPharma stock?

You can no longer sell stock of Zenas BioPharma on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Zenas BioPharma stock?

You can no longer sell stock of Zenas BioPharma on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

To learn more about Zenas BioPharma stock

Is Zenas BioPharma a public company?

Zenas BioPharma is now a public company traded on NASDAQ with ticker ZBIO.

What is Zenas BioPharma’s stock price?

The stock price of Zenas BioPharma is not currently available.

What is Zenas BioPharma’s stock ticker symbol?

The ticker symbol of Zenas BioPharma is ZBIO.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Zenas BioPharma funding rounds and valuation

Total funding $--

Funding history chart

Company details

Zenas BioPharma is a biopharmaceutical company that aims to develop inflammatory and immunology therapies. The company has a mission to address the unmet needs of patients who experience autoimmune and rare diseases by discovering differentiated approaches to current treatments. The company's lead product candidate is obexelimab, which is a bifunctional monoclonal antibody that was designed to inhibit B-cell activity. Zenas BioPharma was founded in 2019 by Lonnie Moulder Jr. and is headquartered in Waltham, MA.
Founded
2020
Headquarters
Waltham, MA, United States
Leadership
Lonnie Moulder Jr.
Founder & Chief Executive Officer
Joseph Farmer JD
President & Chief Operating Officer
Jennifer Fox
Chief Financial Officer & Chief Business Officer
Caroline Chevalier
Chief Human Resources Officer
Tanya Fischer
Chief Medical Officer & Head of Research and Development
Board
Hongbo Lu Ph.D
Vivo Capital
Jake Nunn
SR One Capital Management
James Boylan
Enavate Sciences
Marietta Wu Ph.D
Quan Capital
Patrick Enright
Longitude Capital

Zenas BioPharma investors also invested in these private compaies

Enavate Sciences
Fairmount Funds Management
Federated Hermes
Lepu Biopharma
Norwest Venture Partners
Pivotal Bioventure Partners
Quan Capital
Quantum Ventures
Sr One Capital Management
Superstring Capital Management
Tellus Bioventures
Wuxi Biologics
Xencor

Zenas BioPharma news and media highlights

Zenas, with new funding, aims dual-targeting antibody at lupus and MS

In a series C funding round, Zenas raised $200 million from investors.
Browse More Insights

Explore private companies in the Biotech & Pharma sector

Sector: Healthcare
Subsector: Biotech & Pharma
Trade Metrics Last Funding Round
Company Forge Price Last Matched Price Share Class Post-Money Valuation 3 Price Per Share Amount Raised
Altos LabsAltos Labs--$xx.xxSeries C$6.33B$25.02$1.5B
ApnimedApnimed--$xx.xxSeries D$394.07MM$9.65$16.5MM
BillionToOneBillionToOne--$xx.xxSeries D$1.25B$28.02$130.47MM
Colossal BiosciencesColossal Biosciences--$xx.xxSeries C$10.2B$24.89$200MM
Human LongevityHuman Longevity--$xx.xxSeries B-1$185.79MM$0.31$32MM
Isomorphic LabsIsomorphic Labs--$xx.xx--------
Life BiosciencesLife Biosciences--$xx.xx--------
Precision NeurosciencePrecision Neuroscience--$xx.xxSeries C$542.69MM$5.70$102MM
SetPoint MedicalSetPoint Medical--$xx.xxSeries D$471.62MM$1.51$115MM
Shoulder InnovationsShoulder Innovations--$xx.xx--------

Forge is your trusted partner to buy and sell Zenas BioPharma stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Updated on: Jul 15, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Most active companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.